Genetic Testing

  • Placeholder

    Hereditary Cancer Gene Panel – 57 ACMG Genes for Genetic Risk Screening

    4.000,00 د.إ

    The **Hereditary Cancer Gene Panel (57 ACMG Genes)** is a comprehensive genetic test designed to assess inherited cancer risk by analyzing 57 clinically significant genes recommended by the **American College of Medical Genetics (ACMG)**. This panel identifies mutations linked to various hereditary cancers, including **breast, ovarian, colorectal, prostate, and pancreatic cancers**, enabling early detection and personalized risk management. Key features include **next-generation sequencing (NGS) technology** for high accuracy, expert-reviewed results, and actionable insights for **preventive care and targeted treatment strategies**. Ideal for individuals with a family history of cancer, this test empowers proactive healthcare decisions, offering **lifelong benefits through early intervention and precision medicine**.

  • Placeholder

    Hereditary Cancer Panel 57 ACMG 20 HBOC & 865 literature reviewed Genes

    4.000,00 د.إ

    The **Hereditary Cancer Panel 57 ACMG 20 HBOC & 865 Literature-Reviewed Genes** is a comprehensive genetic test designed to assess hereditary cancer risk. It analyzes **57 key genes**, including the **ACMG 20** and **HBOC-related genes**, alongside **865 literature-reviewed genes**, ensuring a thorough evaluation of cancer predisposition. This panel covers a wide range of hereditary cancers, including **breast, ovarian, colorectal, and more**, providing **clinically actionable insights** for early detection and personalized risk management. Utilizing **advanced sequencing technology**, it delivers **high accuracy and reliability**, making it an essential tool for **patients, healthcare providers, and genetic counselors**. Its unique combination of **expert-curated genes and extensive literature review** enhances diagnostic precision, setting it apart as a **cutting-edge solution for hereditary cancer risk assessment**.

  • HLA Typing - B5 (PCR)

    HLA Typing – B5 (PCR)

    1.250,00 د.إ

    Sample Type : Whole Blood
    Methodology : Real-time PCR
    TAT : 10 Days

  • Placeholder

    Jak 2 Exon 12-15 Mutation Analysis | Accurate Genetic Testing & Results

    2.720,00 د.إ

    The Jak 2 Exon 12-15 Mutation Analysis is a specialized genetic test designed to detect mutations in exons 12-15 of the JAK2 gene, which are associated with myeloproliferative neoplasms (MPNs) such as polycythemia vera (PV) and other hematologic disorders. This test offers high sensitivity and specificity, enabling early and accurate diagnosis, which is crucial for targeted treatment decisions and disease monitoring. Unlike standard JAK2 V617F mutation tests, this analysis identifies rare but clinically significant mutations, providing comprehensive genetic profiling for patients with suspected MPNs. Its advanced molecular technology ensures reliable results, supporting personalized therapeutic strategies and improving patient outcomes.

  • Placeholder

    Life Geno DNA Wellness Test – Comprehensive Genetic Health & Fitness Screening Panel

    3.750,00 د.إ

    The Life Geno-DNA Based Comprehensive Wellness Screening Panel is an advanced genetic testing solution that analyzes your DNA to provide personalized insights into your overall health, wellness, and disease risk. Key features include in-depth analysis of genetic markers related to nutrition, fitness, metabolism, sleep, stress, and predisposition to chronic conditions.

  • Placeholder

    Mitochondrial DNA Sequencing | High-Accuracy mtDNA Analysis for Research & Medicine

    3.750,00 د.إ

    Mitochondrial DNA (mtDNA) Sequencing provides high-resolution analysis of mitochondrial genomes, enabling precise identification of genetic variations. Key features include full-length mtDNA sequencing, high accuracy, and deep coverage, ensuring reliable detection of mutations and heteroplasmy. Benefits include applications in ancestry research, forensic identification, disease association studies, and evolutionary biology.

  • MTHFR C677T Gene Mutation Test – DNA Analysis for Genetic Health Insights

    MTHFR C677T Gene Mutation Test – DNA Analysis for Genetic Health Insights

    1.600,00 د.إ

    The MTHFR Mutation (C677T) Analysis is a genetic test that identifies the presence of the C677T variant in the MTHFR gene, which can impact folate metabolism and homocysteine levels. Key features include accurate DNA analysis using a simple saliva or cheek swab sample, fast turnaround time, and clear, actionable results. Benefits include personalized insights into potential health risks such as cardiovascular issues, fertility challenges, and neurological conditions, enabling targeted lifestyle and nutritional interventions. Its unique selling point lies in empowering individuals with genetic knowledge to make informed health decisions and optimize wellness through precision nutrition.

  • Placeholder

    Oncomine Acute Myeloid Leukemia (AML) Panel – Targeted NGS Solution for AML Research

    5.500,00 د.إ

    The Oncomine Acute Myeloid Leukaemia (AML) Panel is a targeted next-generation sequencing (NGS) assay designed for comprehensive genomic profiling of AML. It enables simultaneous detection of key mutations, gene fusions, and copy number variations across clinically relevant genes associated with AML.

  • Oncomine Comprehensive myeloid/ Leukemia Panel (DNA + RNA fusions)

    Oncomine Comprehensive myeloid/ Leukemia Panel (DNA + RNA fusions)

    5.500,00 د.إ

    The Oncomine Comprehensive Myeloid/Leukemia Panel (DNA + RNA fusions) is a next-generation sequencing (NGS) assay designed for comprehensive genomic profiling of myeloid malignancies and leukemias. It simultaneously analyzes DNA and RNA to detect key mutations, copy number variations, and gene fusions across a broad range of clinically relevant genes.

  • Placeholder

    Oncomine Myeloproliferative Neoplasm (MPN) Panel – Accurate NGS Testing for MPN Mutations

    5.500,00 د.إ

    The Oncomine Myeloproliferative Neoplasm (MPN) Panel is a targeted next-generation sequencing (NGS) assay designed for the comprehensive detection of key driver mutations in myeloproliferative neoplasms. It enables the simultaneous analysis of JAK2, CALR, and MPL genes, which are critical for MPN diagnosis and classification. The panel offers high sensitivity, detecting low-frequency variants with as little as 10 ng of input RNA or DNA, making it ideal for limited or degraded samples.

  • Placeholder

    Panorama Extended Prenatal Screening by Natera – Advanced Non-Invasive Genetic Test

    4.500,00 د.إ

    Panorama Extended Prenatal Screening is a cutting-edge, non-invasive prenatal test (NIPT) designed to provide expectant parents with critical insights into their baby’s health.

    Sample Type : Maternal blood

    Methodology : PCR-single nucleotide polymorphism (SNP)-based technology

    TAT : 10 Days

  • Placeholder

    Recurrent Abortion Genetic Profile Test – Protein C, S, Factor V Leiden & Antithrombin III Analysis

    2.950,00 د.إ

    Recurrent Abortion Profile I (Genetic Origin) is a specialized diagnostic panel designed to identify genetic and protein-based causes of recurrent pregnancy loss.

    Sample Type : Whole Blood+Plasma

    Methodology : NA

    TAT : “7 Days(IH), APCR (OT)-14 days”

  • Placeholder

    ROS1 FISH Test – Accurate Genetic Testing for Targeted Cancer Therapy

    3.750,00 د.إ

    The **Ros1 – Fish Test** is a highly sensitive and reliable fluorescence in situ hybridization (FISH) assay designed for the detection of **ROS1 gene rearrangements** in tumor samples. This test is crucial for identifying patients who may benefit from targeted therapies, particularly in **non-small cell lung cancer (NSCLC)**. Key features include **high specificity and accuracy**, rapid turnaround time, and **direct visualization of gene rearrangements** at the cellular level. Its benefits include **early and precise diagnosis**, enabling personalized treatment decisions and improving patient outcomes. The **unique selling point** of the Ros1 – Fish Test is its **proven clinical utility in guiding targeted therapy selection**, making it an essential tool for oncologists and pathologists in precision medicine.

  • SPINAL MUSCULAR ATROPHY (SMA)

    SPINAL MUSCULAR ATROPHY (SMA) Test – Fast & Accurate Genetic Screening

    2.000,00 د.إ

    Get the SMA Genetic Test in Dubai to detect SMN1 gene mutations. Early screening for newborns & couples. Accurate, fast results. Book your test today!

  • Placeholder

    Whole Exome Sequencing

    5.375,00 د.إ

    Whole Exome Sequencing (WES) is a powerful genetic testing method that sequences all protein-coding regions (exons) of the genome, covering approximately 1-2% of the DNA where most disease-causing mutations occur. It offers a cost-effective alternative to whole genome sequencing while providing high-depth coverage for accurate variant detection. WES enables the identification of genetic mutations linked to inherited disorders, cancer, and rare diseases, making it a valuable tool for clinical diagnostics, personalized medicine, and research.

  • Placeholder

    Y Chromosome Microdeletion Test for Men – Accurate Male Infertility Screening

    2.800,00 د.إ

    The Y Chromosome Microdeletion (YCMD) Blood Test is a specialized genetic screening designed exclusively for males to detect microdeletions in the Y chromosome, a key factor in male infertility. This test identifies deletions in the AZF (Azoospermia Factor) regions, which are crucial for sperm production.

WhatsApp Call